Abstract
BackgroundAcute myeloid leukemia (AML) is the most common acute leukemia in adults and the treatment of AML, especially monocytic AML subtypes still has a poor outcome. Therapies targeting CD33 and...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
